(2,6-difluorophenyl)-[(3R)-3-[1-(3-pyridin-4-yl-1H-indazol-5-yl)triazol-4-yl]piperidin-1-yl]methanol
C26H23F2N7O — CID 139472520
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2,6-difluorophenyl)-[(3R)-3-[1-(3-pyridin-4-yl-1H-indazol-5-yl)triazol-4-yl]piperidin-1-yl]methanol
(2,6-difluorophenyl)-[(3R)-3-[1-(3-pyridin-4-yl-1H-indazol-5-yl)triazol-4-yl]piperidin-1-yl]methanol (PubChem CID 139472520) has the molecular formula C26H23F2N7O and a molecular weight of 487.51 g/mol. Its IUPAC name is (2,6-difluorophenyl)-[(3R)-3-[1-(3-pyridin-4-yl-1H-indazol-5-yl)triazol-4-yl]piperidin-1-yl]methanol.
Molecular Properties
| Compound Name | (2,6-difluorophenyl)-[(3R)-3-[1-(3-pyridin-4-yl-1H-indazol-5-yl)triazol-4-yl]piperidin-1-yl]methanol |
|---|---|
| PubChem CID | 139472520 |
| Molecular Formula | C26H23F2N7O |
| Molecular Weight | 487.51 g/mol |
| Exact Mass | 487.19 |
| IUPAC Name | (2,6-difluorophenyl)-[(3R)-3-[1-(3-pyridin-4-yl-1H-indazol-5-yl)triazol-4-yl]piperidin-1-yl]methanol |
| SMILES | OC(c1c(F)cccc1F)N1CCC[C@@H](c2cn(-c3ccc4[nH]nc(-c5ccncc5)c4c3)nn2)C1 |
| InChI | InChI=1S/C26H23F2N7O/c27-20-4-1-5-21(28)24(20)26(36)34-12-2-3-17(14-34)23-15-35(33-31-23)18-6-7-22-19(13-18)25(32-30-22)16-8-10-29-11-9-16/h1,4-11,13,15,17,26,36H,2-3,12,14H2,(H,30,32)/t17-,26?/m1/s1 |
| InChIKey | AJGAPEHDUFCJBS-SIHBAMTISA-N |
| XLogP | 4.35 |
| TPSA | 95.75 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 487.51 |
| LogP ≤ 5 | 4.35 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139472520 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.